These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 32160658)

  • 1. Interchangeable Insulins - New Pathways for Safe, Effective, Affordable Diabetes Therapy.
    Socal MP; Greene JA
    N Engl J Med; 2020 Mar; 382(11):981-983. PubMed ID: 32160658
    [No Abstract]   [Full Text] [Related]  

  • 2. New Insulins, Biosimilars, and Insulin Therapy.
    Danne T; Heinemann L; Bolinder J
    Diabetes Technol Ther; 2018 Feb; 20(S1):S55-S70. PubMed ID: 29437477
    [No Abstract]   [Full Text] [Related]  

  • 3. New Insulins, Biosimilars, and Insulin Therapy.
    Danne T; Heinemann L; Bolinder J
    Diabetes Technol Ther; 2017 Feb; 19(S1):S42-S58. PubMed ID: 28192016
    [No Abstract]   [Full Text] [Related]  

  • 4. New Insulins, Biosimilars, and Insulin Therapy.
    Danne T; Heinemann L; Bolinder J
    Diabetes Technol Ther; 2020 Feb; 22(S1):S32-S46. PubMed ID: 32069160
    [No Abstract]   [Full Text] [Related]  

  • 5. Biosimilar insulins are coming: what they are, what you need to know.
    Edelman S; Polonsky WH; Parkin CG
    Curr Med Res Opin; 2014 Nov; 30(11):2217-22. PubMed ID: 25105307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New Insulins, Biosimilars, and Insulin Therapy.
    Danne T; Heinemann L; Bolinder J
    Diabetes Technol Ther; 2019 Feb; 21(S1):S57-S78. PubMed ID: 30785319
    [No Abstract]   [Full Text] [Related]  

  • 7. Introduction of biosimilar insulins in Europe.
    Davies M; Dahl D; Heise T; Kiljanski J; Mathieu C
    Diabet Med; 2017 Oct; 34(10):1340-1353. PubMed ID: 28608570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Cost-Effectiveness of Intermediate-Acting, Long-Acting, Ultralong-Acting, and Biosimilar Insulins for Type 1 Diabetes Mellitus: A Systematic Review.
    Saunders H; Pham B; Loong D; Mishra S; Ashoor HM; Antony J; Darvesh N; Bains SK; Jamieson M; Plett D; Trivedi S; Yu CH; Straus SE; Tricco AC; Isaranuwatchai W
    Value Health; 2022 Jul; 25(7):1235-1252. PubMed ID: 35341688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New Insulins, Biosimilars, and Insulin Therapy.
    Danne T; Heinemann L; Bolinder J
    Diabetes Technol Ther; 2021 Jun; 23(S2):S46-S68. PubMed ID: 34061629
    [No Abstract]   [Full Text] [Related]  

  • 10. New Insulins, Biosimilars, and Insulin Therapy.
    Danne T; Heinemann L; Pieber TR
    Diabetes Technol Ther; 2023 Feb; 25(S1):S44-S69. PubMed ID: 36802184
    [No Abstract]   [Full Text] [Related]  

  • 11. Biosimilar Insulin and Costs: What Can We Expect?
    Heinemann L
    J Diabetes Sci Technol; 2015 Sep; 10(2):457-62. PubMed ID: 26350722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New Insulins, Biosimilars, and Insulin Therapy.
    Danne T; Heinemann L; Bolinder J
    Diabetes Technol Ther; 2016 Feb; 18 Suppl 1():S43-55. PubMed ID: 26836429
    [No Abstract]   [Full Text] [Related]  

  • 13. Biosimilar insulins are coming: the top 10 things you should know.
    Blumer I; Edelman S
    Postgrad Med; 2014 May; 126(3):107-10. PubMed ID: 24918796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New Medications for the Treatment of Diabetes.
    Garg SK; Rewers AH; Akturk HK
    Diabetes Technol Ther; 2018 Feb; 20(S1):S139-S153. PubMed ID: 29437472
    [No Abstract]   [Full Text] [Related]  

  • 15. The impact of biosimilar insulins on the diabetes landscape.
    White J; Wagner A; Patel H
    J Manag Care Spec Pharm; 2022 Jan; 28(1):91-98. PubMed ID: 34726499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biosimilar insulins: guidance for data interpretation by clinicians and users.
    Heinemann L; Home PD; Hompesch M
    Diabetes Obes Metab; 2015 Oct; 17(10):911-8. PubMed ID: 25974131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulary Considerations for Insulins Approved Through the 505(b)(2) "Follow-on" Pathway.
    Rasmussen JT; Ipema HJ
    Ann Pharmacother; 2019 Feb; 53(2):204-210. PubMed ID: 30122087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of Insulin Pump in Neonates and Toddlers.
    Klingensmith GJ
    Diabetes Technol Ther; 2015 Dec; 17(12):857-9. PubMed ID: 26618720
    [No Abstract]   [Full Text] [Related]  

  • 19. Insulin pumps improve glucose control in children with type 1 diabetes, study finds.
    Mayor S
    BMJ; 2015 Nov; 351():h5998. PubMed ID: 26556780
    [No Abstract]   [Full Text] [Related]  

  • 20. Biosimilar products are not bioidentical.
    Garber AJ
    J Diabetes; 2015 Mar; 7(2):153-4. PubMed ID: 25395269
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.